Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Digital Photography Guide for Dermatologists With Special Considerations for Diverse Populations.
Journal: JAMA dermatology
Published: April 16, 2025
Lenabasum, a cannabinoid type 2 receptor agonist, exerts anti-inflammatory effects in dermatomyositis.
Journal: The Journal of investigative dermatology
Published: March 29, 2024
Plasmacytoid Dendritic Cells Are Not Major Producers of Type 1 IFN in Cutaneous Lupus: An In-Depth Immunoprofile of Subacute and Discoid Lupus.
Journal: The Journal of investigative dermatology
Published: January 18, 2023
Scattered Flesh-Colored Papules in a Linear Array in the Setting of Diffuse Skin Thickening.
Journal: Cutis
Published: October 11, 2022
Clinical research: photo validation study using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) scores in patients with dermatomyositis.
Journal: The British journal of dermatology
Published: April 13, 2022
Autoimmune Skin Disease Exacerbations Following COVID-19 Vaccination.
Journal: Frontiers in immunology
Published: March 18, 2022
Correction to: Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo efects of LenabasumTM.
Journal: Arthritis research & therapy
Published: March 12, 2022
Multidimensional Immune Profiling of Cutaneous Lupus Erythematosus In Vivo Stratified by Patient Response to Antimalarials.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: November 19, 2021
Mycophenolate mofetil and methotrexate efficacy in dermatomyositis.
Journal: The British journal of dermatology
Published: November 09, 2021
Dermatomyositis associated with hyponatremia and anasarca.
Journal: JAAD case reports
Published: September 20, 2021
Last Updated: 09/26/2026